Financial PerformanceAytu reported F4Q25 results with total revenue of $15.1M, which was below both consensus and estimates, leading to a decrease in stock value.
Revenue DeclineThe ADHD segment, Aytu's primary source of revenue, experienced a decline and missed sales estimates due to various factors impacting the business.
Sales EstimatesDespite reducing revenue and EBITDA estimates, the analyst remains bullish on the EXXUA opportunity, reiterating a Buy recommendation.